Ticker Scorecard - GOSS Basics Company: Gossamer Bio, Inc. IPO Date: February 4, 2019 Sector: Healthcare Industry: Biotech Market Cap: $191.23M Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 3.48% Avg Daily Range (30 D): $0.04 | 4.55% Avg Daily Range (90 D): $0.03 | 3.29% Institutional Daily Volume Avg Daily Volume: 1.05M Avg Daily Volume (30 D): 1.29M Avg Daily Volume (90 D): .94M Trade Size Avg Trade Size (Sh.): 171 Avg Trade Size (Sh.) (30 D): 412 Avg Trade Size (Sh.) (90 D): 378 Institutional Trades Total Inst.Trades: 1,264 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $.76M Avg Inst. Trade (90 D): $.69M Avg Inst. Trade Volume: .24M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.7M Avg Closing Trade (30 D): $.53M Avg Closing Trade (90 D): $.61M Avg Closing Volume: 303.99K     News Jan 14, 2025 @ 6:00 PM Evolving Landscape of Cardiology Segment: Key Mark... Source: Delveinsight Dec 2, 2024 @ 12:30 PM XOMA Royalty Acquires Pulmokine for $20 Million Ad... Source: Globe Newswire Jun 25, 2024 @ 6:39 PM Gossamer Bio's Clean Safety Profile Differentiates... Source: Vandana Singh May 19, 2024 @ 10:35 AM Wall Street Breakfast: The Week Ahead Source: Wall Street Breakfast Mar 7, 2024 @ 2:55 PM Should You Buy Gossamer Bio (GOSS) After Golden Cr... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.25 $-.14 $.22 Diluted EPS $-.25 $-.14 $.22 Revenue $ 105.32M $ 9.48M $ 95.84M Gross Profit $ $ $ Net Income / Loss $ -71.65M $ -30.8M $ 49.23M Operating Income / Loss $ -72.82M $ -33.92M $ 52.09M Cost of Revenue $ $ $ Net Cash Flow $ -54.36M $ -58.51M $ 48.02M PE Ratio